Search Contract Opportunities

Rabeprazole Sodium Delayed Release Tablets   3

ID: SPE2D220R0061 • Type: Solicitation • Match:  100%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
Does this contract have any security clearance requirements?
I'd like to anonymously submit a question to the procurement officer(s)

Description

Posted: April 23, 2020, 4:22 p.m. EDT

Amendment 0007 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets extends the closing date until April 30, 2020 at 3:00 PM DST. Submission of offers via DIBBS submittial.

Amendment 0006 supercedes Amendment 0005 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets is to allow only DIBBS submittial of offers. Any other submittial of offers is not acceptable. Closing date has been extended until April 23, 2020 at 3:00 PM DST.

Amendment 0005 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets extends the closing date until April 23, 2020 at 3:00 PM DST and to update email submissions of offers.

Amendment 0004 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets closing date extended until April 16, 2020 at 3:00 PM DST to allow email submissions of offers.

Amendment 0003 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets closing date extended until April 09, 2020 at 3:00 PM DST.

Amendment 0002 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets to incoproate three (3) DFARS clauses into solicitation.

Amendment 0001 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets to incorporate two (2) DFARS clauses into solicitation.

Solicitation for Rabeprazole Sodium DR Tablets SPE2D2-20-R-0061.

Posted: April 23, 2020, 4:17 p.m. EDT
Posted: April 13, 2020, 4:26 p.m. EDT
Posted: April 13, 2020, 1:15 p.m. EDT
Posted: April 6, 2020, 10:52 a.m. EDT
Posted: March 17, 2020, 8:56 a.m. EDT
Posted: March 11, 2020, 5:04 p.m. EDT
Posted: March 3, 2020, 4:20 p.m. EST
Posted: Feb. 18, 2020, 12:57 p.m. EST
Show All

Overview

Agency
DLA Troop Support - Medical [DoD - DLA]
Response Deadline
April 30, 2020, 3:00 p.m. EDT (original: March 19, 2020, 3:00 p.m. EDT) Past Due
Posted
Feb. 18, 2020, 12:57 p.m. EST (updated: April 23, 2020, 4:22 p.m. EDT)
Set Aside
None
NAICS
325412 - Pharmaceutical Preparation Manufacturing
PSC
6505 - Drugs And Biologicals
Place of Performance
Not Provided
Source
Open
Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Average
On 2/18/20 DLA Troop Support - Medical issued Solicitation SPE2D220R0061 for Rabeprazole Sodium Delayed Release Tablets due 4/30/20. The opportunity was issued full & open with NAICS 325412 and PSC 6505.
Primary Contact
Name
Phyllis Daraio   Profile
Email
phyllis.daraio@dla.mil
Phone
(215) 737-7941

Documents

Posted documents for Solicitation SPE2D220R0061

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Solicitation SPE2D220R0061

Award Notifications

Agency published notification of awards for Solicitation SPE2D220R0061

IDV Awards

Indefinite delivery vehicles awarded through Solicitation SPE2D220R0061

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation SPE2D220R0061

Similar Active Opportunities

Open contract opportunities similar to Solicitation SPE2D220R0061

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEFENSE LOGISTICS AGENCY (DLA) > TROOP SUPPORT MEDICAL > DLA TROOP SUPPORT
FPDS Organization Code
97AS-SPE2D2
Source Organization Code
500045947
Last Updated
April 23, 2020
Last Updated By
PI33_DR_IAE_51681
Archive Date
Jan. 29, 2026